2025.05.16
MileCell Bio, a leading provider of primary hepatocytes, liver microsomes, and related products for ADME and toxicology research, is excited to announce its participation in the BIO International Convention, which will be held from June 16 to 19, 2025, in Boston, Massachusetts.
The BIO International Convention 2025, hosted by the Biotechnology Innovation Organization (BIO), is the world’s largest and most influential biotechnology event, attracting over 19,600 attendees from 70+ countries. Held at the San Diego Convention Center, this four-day event serves as a nexus for global biopharma leaders, startups, investors, and policymakers to drive innovation and forge partnerships across drug discovery, advanced therapies, and sustainable healthcare solutions
MileCell Bio's product portfolio includes a wide range of solutions for ADME and toxicology research, such as high-quality human & animal primary cells and cell culture media/ reagents. These products are designed to support
researchers in their efforts to understand the metabolism and toxicity of new drug candidates. The company's commitment to quality and innovation has made it a trusted partner for many leading pharmaceutical and biotechnology companies.
The 2025 BIO International Convention will provide MileCell Bio with an excellent platform to engage with the toxicology community, share its latest findings, and explore new collaborations. The company looks forward to meeting with researchers, scientists, and industry professionals to discuss the latest advancements in toxicology and how MileCell Bio's products can contribute to their work.
Join MileCell Bio (Booth #1885） at the 2025 BIO International Convention to explore cutting-edge science, connect with leading experts, and discover solutions for your research needs. For more information about the event, visit the official BIO2025 website：About BIO 2025
